GGrantIndex
Sort

39,280 grants matching leukemia

Efficacy of a novel small-molecule splicing modulator in chronic lymphocytic leukemia (CLL)

$399,999
Thomas Roy Webb · Wildflower Biopharma Inc · R41 · FY2020 · CA

Extending the in vivo half-life of a novel engineered mammalian asparaginase via its binding to human serum albumin

$399,999
Amanda M Schalk · Enzyme By Design, Inc. · R43 · FY2020 · CA

Phase 2 Study of Abatacept with Calcineurin Inhibition and Methotrexate for GVHD

$399,999
Leslie S Kean · Seattle Children'S Hospital · R01 · FY2015 · FD

Development of NEO212, A Novel Oral Drug for the Treatment of Acute Myeloid Leukemia

$399,998
Thomas C Chen · Neonc Technologies, Inc. · R41 · FY2025 · CA

Expansion and Distribution of Stem Cells

$399,992
Wicell Research Institute · R24 · FY2003 · RR

Project 1: Mitotic Gene Bookmarking as an Epigenetic Mechanism to Maintain the Mammary Epithelial Phenotype

$399,988
Gary S. Stein · University Of Vermont & St Agric College · P01 · FY2025 · CA

Expansion and Distribution of Stem Cells

$399,982
Wicell Research Institute · R24 · FY2002 · RR

Stroma-penetrating nanomedicine to improve treatment for pancreatic cancer

$399,970
Katherine Marie Eichinger · Duo Oncology Inc · R41 · FY2024 · CA

Feasibility study of developing SEAK-114 for the treatment of pediatric cancers

$399,964
Zhongzhi Wu · Seak Therapeutics, Llc · R43 · FY2020 · CA

MECHANISMS OF GVHD PREVENTION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE

$399,948
Leo Luznik · Johns Hopkins University · R01 · FY2013 · HL

Endothelial-Derived Angiocrine Factors in Progression of Brain Tumors

$399,944
Shahin Rafi · Fred Hutchinson Cancer Research Center · U54 · FY2014 · CA

Role of MELK in glioblastomas

$399,939
Alexey V Terskikh · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2011 · NS

Role of MELK in glioblastomas

$399,939
Alexey V Terskikh · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2012 · NS

HEMOPOIETIC STEM CELL DIFFERENTIATION TO MACROPHAGES

$399,801
Yeshiva University · R01 · FY2000 · CA

Evaluation of Genetic Therapy in Fancc and Fanca Mice

$399,793
David W. Clapp · Indiana Univ-Purdue Univ At Indianapolis · P01 · FY2007 · HL

Role of APOBEC3 in in vivo Restriction of Retrovirus Infection

$399,750
Susan R Ross · University Of Illinois At Chicago · R01 · FY2019 · AI

Role of APOBEC3 in in vivo Restriction of Retrovirus Infection

$399,750
Susan R Ross · University Of Illinois At Chicago · R01 · FY2018 · AI

MLL Function in the Maintenance of the Blood Forming System

$399,750
Patricia A Ernst · Dartmouth College · R01 · FY2008 · HL

MLL Function in the Maintenance of the Blood Forming System

$399,750
Patricia A Ernst · Dartmouth College · R01 · FY2009 · HL

MLL Function in the Maintenance of the Blood Forming System

$399,750
Patricia A Ernst · Dartmouth College · R01 · FY2010 · HL

The role of EVI1-induced hypermethylation in leukemogenesis.

$399,750
Zhijian Qian · University Of Illinois At Chicago · R01 · FY2017 · HL

MLL Function in the Maintenance of the Blood Forming System

$399,750
Patricia A Ernst · Dartmouth College · R01 · FY2007 · HL

A new molecular therapy against ocular herpes

$399,750
Deepak Shukla · University Of Illinois At Chicago · R01 · FY2016 · EY

Biochemistry of Leukemia Virus Core Binding Factor

$399,750
Nancy Asmussen Speck · Dartmouth College · R01 · FY2008 · HL

Growth factors and engineered stroma for hematopoietic stem csll (HSC) expansion

$399,750
Harvey F Lodish · Whitehead Institute For Biomedical Res · R01 · FY2007 · DK